Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Selegiline, a monoamine oxidase (MAO) inhibitor, is FDA-approved as an adjunct treatment in the management of patients with Parkinson disease and as a treatment for a major depressive disorder (MDD) in adults.